VIYASH

Sequent Scientific Limited, previously known as Sequent Scientific Ltd. before its merger and renaming as Viyash Scientific Ltd., is an integrated pharmaceutical company in the animal health, pharmaceutical, and life sciences industries. The company offers a broad portfolio of animal health products, including finished dose formulations, active pharmaceutical ingredients (APIs), and analytical services. It emphasizes research and development, manufacturing, and compliance with global regulatory standards. Operating across more than five continents and serving over 100 countries, including markets in Europe, the USA, and emerging economies, Sequent Scientific is recognized as a leading animal health company in India. The company's evolution through the merger has positioned it as a comprehensive pharmaceutical player, although precise details regarding incorporation, headquarters, founders, management, subsidiaries, or stock listings are not specified.